12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation (Q38346899)

2 September 2017

title

12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation (English)

1 reference

2 September 2017

0 references

Cathy Wang

1

1 reference

2 September 2017

James H Steer

2

1 reference

2 September 2017

David A Joyce

3

1 reference

2 September 2017

Kirk H M Yip

4

1 reference

2 September 2017

Ming H Zheng

5

1 reference

2 September 2017

Jiake Xu

6

1 reference

2 September 2017

publication date

1 December 2003

1 reference

Journal of Bone and Mineral Research

2 September 2017

published in

1 reference

2 September 2017

volume

18

1 reference

2 September 2017

issue

12

1 reference

2 September 2017

page(s)

2159-2168

1 reference

Bone resorption by osteoclasts

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Differential effects of the 3',5'-cyclic adenosine monophosphate and protein kinase C pathways on the response of isolated rat osteoclasts to calcitonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Effects of peptide fragments of protein kinase C on isolated rat osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Cloning, sequencing, and functional characterization of the rat homologue of receptor activator of NF-kappaB ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Requirement for NF-kappaB in osteoclast and B-cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Glucocorticoids suppress tumor necrosis factor-alpha expression by human monocytic THP-1 cells by suppressing transactivation through adjacent NF-kappa B and c-Jun-activating transcription factor-2 binding sites in the promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

An in vitro transcription analysis of early responses of the human immunodeficiency virus type 1 long terminal repeat to different transcriptional activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-kappaB-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Identification of the critical features of a small peptide inhibitor of JNK activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

12-O-tetradecanoylphorbol-13-acetate (TPA)-induced c-Jun N-terminal kinase (JNK) phosphatase renders immortalized or transformed epithelial cells refractory to TPA-inducible JNK activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Involvement of both extracellular signal-regulated kinase and c-jun N-terminal kinase pathways in the 12-O-tetradecanoylphorbol-13-acetate-induced upregulation of p21(Cip1) in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

PKCalpha-mediated ERK, JNK and p38 activation regulates the myogenic program in human rhabdomyosarcoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced NF-kappaB activation by tea polyphenols, (-)-epigallocatechin gallate and theaflavins

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Inhibition of tumor necrosis factor-alpha -induced nuclear translocation and activation of NF-kappa B by dehydroxymethylepoxyquinomicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Mice lacking the type I interleukin-1 receptor do not lose bone mass after ovariectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

M-CSF neutralization and egr-1 deficiency prevent ovariectomy-induced bone loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Protein kinase C as a drug target: implications for drug or diet prevention and treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Effects of phorbol myristate acetate on rat and chick osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Regulation of osteoprotegerin secretion from primary cultures of human bone marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Regulation of NF-?B activity in murine macrophages: Effect of bacterial lipopolysaccharide and phorbol ester

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Distinct PKC isoforms mediate the activation of cPLA2 and adenylyl cyclase by phorbol ester in RAW264.7 macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Differential requirement for classic and novel PKC isoforms in respiratory burst and phagocytosis in RAW 264.7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Receptor activator of NF-kappaB recruits multiple TRAF family adaptors and activates c-Jun N-terminal kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Bone and haematopoietic defects in mice lacking c-fos

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Prostaglandin E2 directly inhibits bone-resorbing activity of isolated mature osteoclasts mainly through the EP4 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Effect of diacylglycerols on osteoclastic bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Required and nonessential functions of nuclear factor-kappa B in bone cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Interleukin-6 expression and histomorphometry of bones from mice deficient in receptors for interleukin-1 or tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Possible involvement of IkappaB kinase 2 and MKK7 in osteoclastogenesis induced by receptor activator of nuclear factor kappaB ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

Pleiotropic effects of a null mutation in the c-fos proto-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.2003.18.12.2159

10.1359/JBMR.2003.18.12.2159

21 January 2018

Identifiers

DOI

1 reference

release_pi77cw6d4vf4znjy5q7llhp4oe

2 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pi77cw6d4vf4znjy5q7llhp4oe

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference